Key result
A novel nomogram incorporating age, nonalcoholic fatty liver disease, smoking, HDL-C, and LDL-C effectively predicted the risk of carotid atherosclerosis in patients with type 2 diabetes, achieving an AUC of 0.763.
Why the study?
The study was conducted to evaluate the clinical characteristics of carotid atherosclerotic disease in patients with type 2 diabetes mellitus, investigate its risk factors, and develop and validate a nomogram.
Cross-Sectional (n=1,049)
No
Effect estimate: AUC 0.763 (95% CI 0.73-0.80)
A newly developed nomogram incorporating age, NAFLD, smoking, HDL-C, and LDL-C demonstrated good discriminative ability and clinical utility for predicting the risk of carotid atherosclerosis in patients with type 2 diabetes.
May aid carotid atherosclerosis risk stratification in T2D; hypothesis-generating and requires prospective validation.
Introduction: The purpose of this study was to evaluate the clinical characteristics of carotid atherosclerotic disease in patients with type 2 diabetes mellitus, investigate its risk factors, and develop and validate an easy-to-use nomogram. Methods: 1049 patients diagnosed with type 2 diabetes were enrolled and randomly assigned to the training and validation cohorts. Multivariate logistic regression analysis identified independent risk factors. A method combining least absolute shrinkage and selection operator with 10-fold cross-validation was used to screen for characteristic variables associated with carotid atherosclerosis. A nomogram was used to visually display the risk prediction model. Nomogram performance was evaluated using the C index, the area under the receiver operating characteristic curve, and calibration curves. Clinical utility was assessed by decision curve analysis. Results: Age, nonalcoholic fatty liver disease, and OGTT3H were independent risk factors associated with carotid atherosclerosis in patients with diabetes. Age, nonalcoholic fatty liver disease, smoke, HDL-C, and LDL-C were characteristic variables used to develop the nomogram. The area under the curve for the discriminative power of the nomogram was 0.763 for the training cohort and 0.717 for the validation cohort. The calibration curves showed that the predicted probability matched the actual likelihood. The results of the decision curve analysis indicated that the nomograms were clinically useful. Discussion: A new nomogram was developed and validated for assessing the incident risk of carotid atherosclerotic in patients with diabetes; this nomogram may act as a clinical tool to assist clinicians in making treatment recommendations.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2023) conducted a cross-sectional in Type 2 diabetes mellitus and carotid atherosclerosis (n=1,049). Nomogram risk prediction model was evaluated on Discriminative power (AUC) of the nomogram in the training cohort (AUC 0.763, 95% CI 0.73-0.80). A novel nomogram incorporating age, nonalcoholic fatty liver disease, smoking, HDL-C, and LDL-C effectively predicted the risk of carotid atherosclerosis in patients with type 2 diabetes, achieving an AUC of 0.763.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: